Patent details

Basic Information

Publication number:

EP2796134

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP141713958

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

Combination of the peptide epoxyketone proteasome inhibitor carfilzomib with melphalan for use in the treatment of multiple myeloma

French Title of Invention:

Combinaison du peptide époxycétone inhibiteur du protéasome carfilzomib avec le melphalan pour utilisation dans le traitement du myélome multiple

German Title of Invention:

Kombination des Peptid-Epoxyketon-Proteasom-Inhibitors Carfilzomib mit Melphalan zur Verwendung bei der Behandlung von multiplem Myelom

SPC Number:

Dates

Filing date:

21/10/2009

Grant date:

07/12/2016

EP Publication Date:

07/12/2016

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

29/10/2014

EP B1 Publication Date:

07/12/2016

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

21/10/2017

Expiration date:

21/10/2029

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

21/10/2009

 

 

Name:

Onyx Therapeutics Inc.

Address:

One Amgen Center Drive, Thousand Oaks, CA 91320, United States (US)

Inventor

1

Name:

Bennett Mark K.

Address:

United States (US)

2

Name:

Kirk Christopher J.

Address:

United States (US)

3

Name:

Demo Susan D.

Address:

United States (US)

Priority

Priority Number:

196945 P

Priority Date:

21/10/2008

Priority Country:

United States (US)

Classification

Main IPC Class:

A61K 31/167;

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages